Original Research
Published on 02 Feb 2024
A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout
in Inflammation
- 9,549 views
- 8 citations
Original Research
Published on 02 Feb 2024
in Inflammation
Original Research
Published on 01 Jun 2022
in Nanobiotechnology
Original Research
Published on 12 Jan 2022
in Inflammation Pharmacology
Original Research
Published on 20 Oct 2021
in Inflammation
Original Research
Published on 05 Jun 2023
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 16 Feb 2022
in Cell Death and Survival
Original Research
Published on 01 Apr 2022
in Molecular Signalling and Pathways
Original Research
Published on 13 Nov 2020
in Neuropharmacology
Original Research
Published on 26 May 2022
in Inflammation
Original Research
Published on 20 Dec 2021
in Inflammation Pharmacology
Original Research
Published on 15 Aug 2022
in Molecular Innate Immunity
Original Research
Published on 30 Sep 2020
in Molecular Innate Immunity
Original Research
Published on 27 Sep 2024
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 10 Mar 2022
in Inflammation
Original Research
Published on 03 Jun 2022
in Autoimmune and Autoinflammatory Disorders
Original Research
Published on 15 Jan 2024
in Cell Physiology